Mª Jose Solana Moga

Gil-Sánchez A.; Gonzalo H.; Canudes M.; Nogueras L.; González-Mingot C.; Valcheva P.; Torres P.; Serrano J.C.; Peralta S.; Solana M.J.; Brieva L.

Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis?

PHARMACEUTICALS 17 -. 01/01/2024.

[doi:10.3390/ph17040459]

Sancho--Saldaña, A; Gil-Sánchez, A; González-Mingot, C; Peralta, S; Solana, MJ; Torres, P; Juanes, A; Quibus, L; Ruiz, E; Sanpedro, E; Quirant-Sánchez, B; Martínez-Cáceres, E; Tello, CR; Presas-Rodríguez, S; Rubio, SG; Baron, BP; Ramio-Torrenta, L; Sotoca, J; González-Suarez, I; Eichau, S; Prieto-Gonzalez, JM; Quilez, MRB; Sabin-Muñoz, J; Sánchez-López, AJ; Calatayud, GL; Calles, C; Sempere, AP; Garces, M; Carmona, O; Moral, E; Hervas, JV; Blanco, Y; Sola-Valls, N; Lara, NT; Forero, L; Brieva, L

Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study

Journal of Clinical Medicine 12 -. 01/12/2023.

[doi:10.3390/jcm12237243]

Torres P; Sancho-Saldaña A; Gil Sánchez A; Peralta S; Solana MJ; Bakkioui S; González-Mingot C; Quibus L; Ruiz-Fernández E; San Pedro-Murillo E; Brieva L

A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies.

JOURNAL OF NEUROLOGY 270 1-12. 01/05/2023.

[doi:10.1007/s00415-023-11575-8]

Gil-Sanchez A; Canudes M; Valcheva P; Nogueras L; González-Mingot C; Hervás JV; Peralta S; Solana MJ; Brieva L

Effects of vortioxetine on cognition and fatigue in patients with multiple sclerosis and depression: a case series study.

CNS & Neurological Disorders-Drug Targets 23 395-401. 26/04/2023.

[doi:10.2174/1871527322666230321093133]

González-Mingot, C; Gil-Sánchez, A; Canudes-Solans, M; Peralta-Moncusi, S; Solana-Moga, MJ; Brieva-Ruiz, L

Preventive treatment can reverse cognitive impairment in chronic migraine

JOURNAL OF HEADACHE AND PAIN 23 -. 01/12/2022.

[doi:10.1186/s10194-022-01486-w]

Sancho-Saldana, A; Gil Sánchez A; Quirant-Sanchez, B; Nogueras, L; Peralta, S; Solana, MJ; Gonzalez-Mingot, C; Gallego, Y; Quibus, L; Ramo-Tello, C; Presas-Rodriguez, S; Martinez-Caceres, E; Torres, P; Hervas, JV; Valls, J; Brieva, L

Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies.

Journal of Clinical Medicine 11 -. 29/04/2022.

[doi:10.3390/jcm11092509]

Gonzalo, H; Nogueras, L; Gil-Sanchez, A; Hervas, JV; Valcheva, P; Gonzalez-Mingot, C; Martin-Gari, M; Canudes, M; Peralta, S; Solana, MJ; Pamplona, R; Portero-Otin, M; Boada, J; Serrano JCE; Brieva, L

Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients

Frontiers in Neuroscience 13 938-938. 04/09/2019.

[doi:10.3389/fnins.2019.00938]

Nogueras, L; Gonzalo, H; Jove, M; Sol, J; Gil-Sanchez, A; Hervas, JV; Valcheva, P; Gonzalez-Mingot, C; Solana, MJ; Peralta, S; Pamplona, R; Brieva, L

Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis

SCIENTIFIC REPORTS 9 11313-11313. 05/08/2019.

[doi:10.1038/s41598-019-47906-x]

Gil, A; Pardinas, B; Hervas, V; Lecina, J; Solana, MJ; Peralta, S; Forne, C; Gonzalez, C; Gonzalo, H; Nogueras, L; Brieva, L

Pilot Study of Telemedicine in multiple sclerosis to evaluate the effectiveness of a telecommunication system for the detection of the clinical activity of the disease in the number of relapses with respect to the standard clinical practice. TELEM

MULTIPLE SCLEROSIS JOURNAL 24 795-796. 01/10/2018.

Gonzalez-Mingot, C; Sanchez-Monge, IR; Purroy, F; Solana-Moga, MJ; Peralta-Moncusi, S; Lazo-Latorre, C; Gil-Villar, MP; Brieva, L

Environmental-analytical risk factors influence on the phenotype of amyotrophic lateral sclerosis in a rural setting

REVISTA DE NEUROLOGIA 65 203-208. 01/09/2017.

[doi:10.33588/rn.6505.2017091]